GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dawnrays Pharmaceutical (Holdings) Ltd (HKSE:02348) » Definitions » Cyclically Adjusted PS Ratio

Dawnrays Pharmaceutical (Holdings) (HKSE:02348) Cyclically Adjusted PS Ratio : 1.45 (As of Dec. 15, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dawnrays Pharmaceutical (Holdings) Cyclically Adjusted PS Ratio?

As of today (2024-12-15), Dawnrays Pharmaceutical (Holdings)'s current share price is HK$1.16. Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was HK$0.80. Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio for today is 1.45.

The historical rank and industry rank for Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio or its related term are showing as below:

HKSE:02348' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.07   Med: 1.85   Max: 4.89
Current: 1.47

During the past 13 years, Dawnrays Pharmaceutical (Holdings)'s highest Cyclically Adjusted PS Ratio was 4.89. The lowest was 1.07. And the median was 1.85.

HKSE:02348's Cyclically Adjusted PS Ratio is ranked better than
69.33% of 639 companies
in the Drug Manufacturers industry
Industry Median: 2.55 vs HKSE:02348: 1.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dawnrays Pharmaceutical (Holdings)'s adjusted revenue per share data of for the fiscal year that ended in Dec23 was HK$0.838. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is HK$0.80 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dawnrays Pharmaceutical (Holdings) Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dawnrays Pharmaceutical (Holdings) Cyclically Adjusted PS Ratio Chart

Dawnrays Pharmaceutical (Holdings) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.76 1.84 2.18 1.68 1.31

Dawnrays Pharmaceutical (Holdings) Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.68 - 1.31 -

Competitive Comparison of Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio falls into.



Dawnrays Pharmaceutical (Holdings) Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.16/0.8
=1.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Dawnrays Pharmaceutical (Holdings)'s adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.838/117.2957*117.2957
=0.838

Current CPI (Dec23) = 117.2957.

Dawnrays Pharmaceutical (Holdings) Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.608 99.707 0.715
201512 0.734 102.015 0.844
201612 0.576 103.225 0.655
201712 0.656 104.984 0.733
201812 0.679 107.622 0.740
201912 0.671 110.700 0.711
202012 0.786 109.711 0.840
202112 0.946 112.349 0.988
202212 0.950 114.548 0.973
202312 0.838 117.296 0.838

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dawnrays Pharmaceutical (Holdings)  (HKSE:02348) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Dawnrays Pharmaceutical (Holdings) Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Dawnrays Pharmaceutical (Holdings)'s Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dawnrays Pharmaceutical (Holdings) Business Description

Traded in Other Exchanges
N/A
Address
338 Hennessy Road, Units 3001-02, 30th Floor, CNT Tower, Wanchai, North Sea Centre, Hong Kong, HKG
Dawnrays Pharmaceutical (Holdings) Ltd is a drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as a component of its international strategies. The company is open to exploring potential acquisitions as a component of its overall growth plan.
Executives
Li Kei Ling
Hung Yung Lai
Fortune United Group Limited 2101 Beneficial owner
Hunwick International Limited 2201 Interest of corporation controlled by you
Keysmart Enterprises Limited 2201 Interest of corporation controlled by you
Iu Pun 2202 Interest of your spouse
Toyo International Investment Limited
Leung Hong Man
Leung Yiu Sing
Chu Shuet Fong
Lo Mei Sai
Time Lead Investments Limited
Li Tung Ming
Fmr Llc 2201 Interest of corporation controlled by you

Dawnrays Pharmaceutical (Holdings) Headlines

No Headlines